2025-01-012025-12-312025-12-31false12496869STUDY AND WONDER LTD2026-07-0485590falseiso4217:GBPxbrli:pure124968692024-12-31124968692025-12-31124968692025-01-012025-12-31124968692023-12-31124968692024-12-31124968692024-01-012024-12-3112496869bus:SmallEntities2025-01-012025-12-3112496869bus:AuditExempt-NoAccountantsReport2025-01-012025-12-3112496869bus:AbridgedAccounts2025-01-012025-12-3112496869bus:PrivateLimitedCompanyLtd2025-01-012025-12-3112496869core:WithinOneYear2025-12-3112496869core:AfterOneYear2025-12-3112496869core:WithinOneYear2024-12-3112496869core:AfterOneYear2024-12-3112496869core:ShareCapital2025-12-3112496869core:SharePremium2025-12-3112496869core:RevaluationReserve2025-12-3112496869core:OtherReservesSubtotal2025-12-3112496869core:RetainedEarningsAccumulatedLosses2025-12-3112496869core:ShareCapital2024-12-3112496869core:SharePremium2024-12-3112496869core:RevaluationReserve2024-12-3112496869core:OtherReservesSubtotal2024-12-3112496869core:RetainedEarningsAccumulatedLosses2024-12-3112496869core:LandBuildings2025-12-3112496869core:PlantMachinery2025-12-3112496869core:Vehicles2025-12-3112496869core:FurnitureFittings2025-12-3112496869core:OfficeEquipment2025-12-3112496869core:NetGoodwill2025-12-3112496869core:IntangibleAssetsOtherThanGoodwill2025-12-3112496869core:ListedExchangeTraded2025-12-3112496869core:UnlistedNon-exchangeTraded2025-12-3112496869core:LandBuildings2024-12-3112496869core:PlantMachinery2024-12-3112496869core:Vehicles2024-12-3112496869core:FurnitureFittings2024-12-3112496869core:OfficeEquipment2024-12-3112496869core:NetGoodwill2024-12-3112496869core:IntangibleAssetsOtherThanGoodwill2024-12-3112496869core:ListedExchangeTraded2024-12-3112496869core:UnlistedNon-exchangeTraded2024-12-3112496869core:LandBuildings2025-01-012025-12-3112496869core:PlantMachinery2025-01-012025-12-3112496869core:Vehicles2025-01-012025-12-3112496869core:FurnitureFittings2025-01-012025-12-3112496869core:OfficeEquipment2025-01-012025-12-3112496869core:NetGoodwill2025-01-012025-12-3112496869core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3112496869core:ListedExchangeTraded2025-01-012025-12-3112496869core:UnlistedNon-exchangeTraded2025-01-012025-12-3112496869core:MoreThanFiveYears2025-01-012025-12-3112496869core:Non-currentFinancialInstruments2025-12-3112496869core:Non-currentFinancialInstruments2024-12-3112496869dpl:CostSales2025-01-012025-12-3112496869dpl:DistributionCosts2025-01-012025-12-3112496869core:LandBuildings2025-01-012025-12-3112496869core:PlantMachinery2025-01-012025-12-3112496869core:Vehicles2025-01-012025-12-3112496869core:FurnitureFittings2025-01-012025-12-3112496869core:OfficeEquipment2025-01-012025-12-3112496869dpl:AdministrativeExpenses2025-01-012025-12-3112496869core:NetGoodwill2025-01-012025-12-3112496869core:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3112496869dpl:GroupUndertakings2025-01-012025-12-3112496869dpl:ParticipatingInterests2025-01-012025-12-3112496869dpl:GroupUndertakingscore:ListedExchangeTraded2025-01-012025-12-3112496869core:ListedExchangeTraded2025-01-012025-12-3112496869dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2025-01-012025-12-3112496869core:UnlistedNon-exchangeTraded2025-01-012025-12-3112496869dpl:CostSales2024-01-012024-12-3112496869dpl:DistributionCosts2024-01-012024-12-3112496869core:LandBuildings2024-01-012024-12-3112496869core:PlantMachinery2024-01-012024-12-3112496869core:Vehicles2024-01-012024-12-3112496869core:FurnitureFittings2024-01-012024-12-3112496869core:OfficeEquipment2024-01-012024-12-3112496869dpl:AdministrativeExpenses2024-01-012024-12-3112496869core:NetGoodwill2024-01-012024-12-3112496869core:IntangibleAssetsOtherThanGoodwill2024-01-012024-12-3112496869dpl:GroupUndertakings2024-01-012024-12-3112496869dpl:ParticipatingInterests2024-01-012024-12-3112496869dpl:GroupUndertakingscore:ListedExchangeTraded2024-01-012024-12-3112496869core:ListedExchangeTraded2024-01-012024-12-3112496869dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-01-012024-12-3112496869core:UnlistedNon-exchangeTraded2024-01-012024-12-3112496869core:NetGoodwill2025-12-3112496869core:IntangibleAssetsOtherThanGoodwill2025-12-3112496869core:LandBuildings2025-12-3112496869core:PlantMachinery2025-12-3112496869core:Vehicles2025-12-3112496869core:FurnitureFittings2025-12-3112496869core:OfficeEquipment2025-12-3112496869core:AfterOneYear2025-12-3112496869core:WithinOneYear2025-12-3112496869core:ListedExchangeTraded2025-12-3112496869core:UnlistedNon-exchangeTraded2025-12-3112496869core:ShareCapital2025-12-3112496869core:SharePremium2025-12-3112496869core:RevaluationReserve2025-12-3112496869core:OtherReservesSubtotal2025-12-3112496869core:RetainedEarningsAccumulatedLosses2025-12-3112496869core:NetGoodwill2024-12-3112496869core:IntangibleAssetsOtherThanGoodwill2024-12-3112496869core:LandBuildings2024-12-3112496869core:PlantMachinery2024-12-3112496869core:Vehicles2024-12-3112496869core:FurnitureFittings2024-12-3112496869core:OfficeEquipment2024-12-3112496869core:AfterOneYear2024-12-3112496869core:WithinOneYear2024-12-3112496869core:ListedExchangeTraded2024-12-3112496869core:UnlistedNon-exchangeTraded2024-12-3112496869core:ShareCapital2024-12-3112496869core:SharePremium2024-12-3112496869core:RevaluationReserve2024-12-3112496869core:OtherReservesSubtotal2024-12-3112496869core:RetainedEarningsAccumulatedLosses2024-12-3112496869core:NetGoodwill2023-12-3112496869core:IntangibleAssetsOtherThanGoodwill2023-12-3112496869core:LandBuildings2023-12-3112496869core:PlantMachinery2023-12-3112496869core:Vehicles2023-12-3112496869core:FurnitureFittings2023-12-3112496869core:OfficeEquipment2023-12-3112496869core:AfterOneYear2023-12-3112496869core:WithinOneYear2023-12-3112496869core:ListedExchangeTraded2023-12-3112496869core:UnlistedNon-exchangeTraded2023-12-3112496869core:ShareCapital2023-12-3112496869core:SharePremium2023-12-3112496869core:RevaluationReserve2023-12-3112496869core:OtherReservesSubtotal2023-12-3112496869core:RetainedEarningsAccumulatedLosses2023-12-3112496869core:AfterOneYear2025-01-012025-12-3112496869core:WithinOneYear2025-01-012025-12-3112496869core:Non-currentFinancialInstrumentscore:CostValuation2025-01-012025-12-3112496869core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-01-012025-12-3112496869core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-01-012025-12-3112496869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-01-012025-12-3112496869core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-01-012025-12-3112496869core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-01-012025-12-3112496869core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3112496869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3112496869core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-01-012025-12-3112496869core:Non-currentFinancialInstrumentscore:CostValuation2025-12-3112496869core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-12-3112496869core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-12-3112496869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-12-3112496869core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-12-3112496869core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-12-3112496869core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-12-3112496869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-12-3112496869core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-12-3112496869core:Non-currentFinancialInstrumentscore:CostValuation2024-12-3112496869core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-12-3112496869core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-12-3112496869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-12-3112496869core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-12-3112496869core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-12-3112496869core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-12-3112496869core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-12-3112496869core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-12-3112496869bus:Director12025-01-012025-12-3112496869bus:Director22025-01-012025-12-31

STUDY AND WONDER LTD

Registered Number
12496869
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2025

STUDY AND WONDER LTD
Company Information
for the year from 1 January 2025 to 31 December 2025

Directors

MARINOPOULOS, Alexis Karolos
MARINOPOULOS, Andreas

Company Secretary

FIDUCI-CORP (UK) SERVICES LIMITED

Registered Address

Speen House
Porter Street
London
W1U 6AJ

Registered Number

12496869 (England and Wales)
STUDY AND WONDER LTD
Balance Sheet as at
31 December 2025

Notes

2025

2024

£

£

£

£

Current assets
Debtors344,89823,376
Cash at bank and on hand1,080,25930,226
1,125,15753,602
Creditors amounts falling due within one year4(381,051)(240,478)
Net current assets (liabilities)744,106(186,876)
Total assets less current liabilities744,106(186,876)
Net assets744,106(186,876)
Capital and reserves
Called up share capital8,6538,653
Profit and loss account735,453(195,529)
Shareholders' funds744,106(186,876)
The financial statements were approved and authorised for issue by the Board of Directors on 4 July 2026, and are signed on its behalf by:
MARINOPOULOS, Andreas
Director
Registered Company No. 12496869
STUDY AND WONDER LTD
Notes to the Financial Statements
for the year ended 31 December 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Foreign currency translation
Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.
Related parties
For the purposes of these financial statements, a related party could be a person or an entity. Careful consideration is given to the definition of a related party to ensure that all related party relationships, transactions and balances are identified. At year end 31st Dec 2025 Study and Wonder Limited owed Choplin Ventures £44,016 (2024: -15,628). Study and Wonder Limited is the wholly owned subsidiary of Choplin Ventures Limited (the parent) in which Andreas Marinopoulos and Alexis Marinopoulos hold a controlling interest. At year end 31st Dec 2025 Study and Wonder Limited was owed £39,824 (2024-£25,854) by Brilliant Microschools Inc. in which Andreas Marinopoulos and Alexis Marinopoulos hold a beneficial interest. At year end 31st Dec 2025 Study and Wonder Limited was owed £3,054 (2024-£1,678) by Movinhand IKE in which Andreas Marinopoulos and Alexis Marinopoulos hold a beneficial interest.
2.Average number of employees

20252024
Average number of employees during the year11
3.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables-7,295
Other debtors44,89816,081
Total44,89823,376
4.Creditors: amounts due within one year

2025

2024

££
Trade creditors / trade payables1,781723
Taxation and social security285,872185,443
Other creditors44,01627,532
Accrued liabilities and deferred income49,38226,780
Total381,051240,478